Cargando…

Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway

Evidence shows that the long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (Lnc-MALAT1) is associated with activation of hepatic stellate cells (HSCs) and liver fibrosis in animal and in vitro studies. However, its roles in human liver fibrosis and the underlying mechanism in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tianqi, Zhang, Chong, Meng, Xiaoming, Zhu, Benshuai, Wang, Siyu, Yuan, Wenkang, Zhang, Sumei, Xu, Jiegou, Zhang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882958/
https://www.ncbi.nlm.nih.gov/pubmed/35237178
http://dx.doi.org/10.3389/fphys.2022.792182
_version_ 1784659812410195968
author Wang, Tianqi
Zhang, Chong
Meng, Xiaoming
Zhu, Benshuai
Wang, Siyu
Yuan, Wenkang
Zhang, Sumei
Xu, Jiegou
Zhang, Chao
author_facet Wang, Tianqi
Zhang, Chong
Meng, Xiaoming
Zhu, Benshuai
Wang, Siyu
Yuan, Wenkang
Zhang, Sumei
Xu, Jiegou
Zhang, Chao
author_sort Wang, Tianqi
collection PubMed
description Evidence shows that the long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (Lnc-MALAT1) is associated with activation of hepatic stellate cells (HSCs) and liver fibrosis in animal and in vitro studies. However, its roles in human liver fibrosis and the underlying mechanism in HSC activation are not yet defined. In our current study, the expression of Lnc-MALAT1 in the fibrotic liver tissues and in the plasma extracelllar vesicles (EVs) of liver fibrosis patients was detected by FISH and qRT-PCR. The results revealed that enhanced expression of Lnc-MALAT1 was co-localized with increased expression of the fibrotic markers (collagen I and α-SMA) and the Wnt/β-catenin signaling proteins (β-catenin, cyclinD1 and c-myc) in the fibrotic liver tissues. The level of Lnc-MALAT1 in the plasma EVs isolated from 60 liver fibrosis patients was significantly increased compared with that of the 46 control patients, and area under receiver operating curve (AUROC) analysis showed that plasma EVs-Lnc-MALAT1 was a potential diagnostic marker for liver fibrosis, especially for high liver fibrosis. Plasma EVs with highly expressed Lnc-MALAT1 derived from high liver fibrosis patients up-regulated the expression of the fibrotic markers and enhanced the Wnt/β-catenin signaling in human hepatic stellate cells LX-2, and the fibrogenic effects in LX-2 were inhibited by Lnc-MALAT1 knock-down. Interestingly, TGF-β1, a potent pro-fibrotic cytokine, promoted the expression of Lnc-MALAT1 in LX-2 and its pro-fibrotic effects were also abolished by siRNA for Lnc-MALAT1, suggesting that Lnc-MALAT1 probably functions as a common mediator in the activation and fibrogenesis of HSCs. Our results indicate that enhanced expression of Lnc-MALAT1 in the fibrotic liver stimulate the activation of HSCs and thus promote their fibrogenic activity. These results also provide evidences that Lnc-MALAT1 is a potential therapeutic target and plasma EVs-Lnc-MALAT1 is a potential diagnostic biomarker for liver fibrosis.
format Online
Article
Text
id pubmed-8882958
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88829582022-03-01 Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway Wang, Tianqi Zhang, Chong Meng, Xiaoming Zhu, Benshuai Wang, Siyu Yuan, Wenkang Zhang, Sumei Xu, Jiegou Zhang, Chao Front Physiol Physiology Evidence shows that the long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (Lnc-MALAT1) is associated with activation of hepatic stellate cells (HSCs) and liver fibrosis in animal and in vitro studies. However, its roles in human liver fibrosis and the underlying mechanism in HSC activation are not yet defined. In our current study, the expression of Lnc-MALAT1 in the fibrotic liver tissues and in the plasma extracelllar vesicles (EVs) of liver fibrosis patients was detected by FISH and qRT-PCR. The results revealed that enhanced expression of Lnc-MALAT1 was co-localized with increased expression of the fibrotic markers (collagen I and α-SMA) and the Wnt/β-catenin signaling proteins (β-catenin, cyclinD1 and c-myc) in the fibrotic liver tissues. The level of Lnc-MALAT1 in the plasma EVs isolated from 60 liver fibrosis patients was significantly increased compared with that of the 46 control patients, and area under receiver operating curve (AUROC) analysis showed that plasma EVs-Lnc-MALAT1 was a potential diagnostic marker for liver fibrosis, especially for high liver fibrosis. Plasma EVs with highly expressed Lnc-MALAT1 derived from high liver fibrosis patients up-regulated the expression of the fibrotic markers and enhanced the Wnt/β-catenin signaling in human hepatic stellate cells LX-2, and the fibrogenic effects in LX-2 were inhibited by Lnc-MALAT1 knock-down. Interestingly, TGF-β1, a potent pro-fibrotic cytokine, promoted the expression of Lnc-MALAT1 in LX-2 and its pro-fibrotic effects were also abolished by siRNA for Lnc-MALAT1, suggesting that Lnc-MALAT1 probably functions as a common mediator in the activation and fibrogenesis of HSCs. Our results indicate that enhanced expression of Lnc-MALAT1 in the fibrotic liver stimulate the activation of HSCs and thus promote their fibrogenic activity. These results also provide evidences that Lnc-MALAT1 is a potential therapeutic target and plasma EVs-Lnc-MALAT1 is a potential diagnostic biomarker for liver fibrosis. Frontiers Media S.A. 2022-02-14 /pmc/articles/PMC8882958/ /pubmed/35237178 http://dx.doi.org/10.3389/fphys.2022.792182 Text en Copyright © 2022 Wang, Zhang, Meng, Zhu, Wang, Yuan, Zhang, Xu and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Wang, Tianqi
Zhang, Chong
Meng, Xiaoming
Zhu, Benshuai
Wang, Siyu
Yuan, Wenkang
Zhang, Sumei
Xu, Jiegou
Zhang, Chao
Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway
title Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway
title_full Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway
title_fullStr Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway
title_full_unstemmed Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway
title_short Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway
title_sort long noncoding rna metastasis-associated lung adenocarcinoma transcript 1 in extracellular vesicles promotes hepatic stellate cell activation, liver fibrosis and β-catenin signaling pathway
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882958/
https://www.ncbi.nlm.nih.gov/pubmed/35237178
http://dx.doi.org/10.3389/fphys.2022.792182
work_keys_str_mv AT wangtianqi longnoncodingrnametastasisassociatedlungadenocarcinomatranscript1inextracellularvesiclespromoteshepaticstellatecellactivationliverfibrosisandbcateninsignalingpathway
AT zhangchong longnoncodingrnametastasisassociatedlungadenocarcinomatranscript1inextracellularvesiclespromoteshepaticstellatecellactivationliverfibrosisandbcateninsignalingpathway
AT mengxiaoming longnoncodingrnametastasisassociatedlungadenocarcinomatranscript1inextracellularvesiclespromoteshepaticstellatecellactivationliverfibrosisandbcateninsignalingpathway
AT zhubenshuai longnoncodingrnametastasisassociatedlungadenocarcinomatranscript1inextracellularvesiclespromoteshepaticstellatecellactivationliverfibrosisandbcateninsignalingpathway
AT wangsiyu longnoncodingrnametastasisassociatedlungadenocarcinomatranscript1inextracellularvesiclespromoteshepaticstellatecellactivationliverfibrosisandbcateninsignalingpathway
AT yuanwenkang longnoncodingrnametastasisassociatedlungadenocarcinomatranscript1inextracellularvesiclespromoteshepaticstellatecellactivationliverfibrosisandbcateninsignalingpathway
AT zhangsumei longnoncodingrnametastasisassociatedlungadenocarcinomatranscript1inextracellularvesiclespromoteshepaticstellatecellactivationliverfibrosisandbcateninsignalingpathway
AT xujiegou longnoncodingrnametastasisassociatedlungadenocarcinomatranscript1inextracellularvesiclespromoteshepaticstellatecellactivationliverfibrosisandbcateninsignalingpathway
AT zhangchao longnoncodingrnametastasisassociatedlungadenocarcinomatranscript1inextracellularvesiclespromoteshepaticstellatecellactivationliverfibrosisandbcateninsignalingpathway